Correlation Between Beta Drugs and Can Fin

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Can Fin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Can Fin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beta Drugs and Can Fin Homes, you can compare the effects of market volatilities on Beta Drugs and Can Fin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Can Fin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Can Fin.

Diversification Opportunities for Beta Drugs and Can Fin

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Beta and Can is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Can Fin Homes in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Can Fin Homes and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Can Fin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Can Fin Homes has no effect on the direction of Beta Drugs i.e., Beta Drugs and Can Fin go up and down completely randomly.

Pair Corralation between Beta Drugs and Can Fin

Assuming the 90 days trading horizon Beta Drugs is expected to generate 1.84 times more return on investment than Can Fin. However, Beta Drugs is 1.84 times more volatile than Can Fin Homes. It trades about 0.12 of its potential returns per unit of risk. Can Fin Homes is currently generating about -0.04 per unit of risk. If you would invest  180,680  in Beta Drugs on September 5, 2024 and sell it today you would earn a total of  43,390  from holding Beta Drugs or generate 24.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Beta Drugs  vs.  Can Fin Homes

 Performance 
       Timeline  
Beta Drugs 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.
Can Fin Homes 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Can Fin Homes has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Can Fin is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Beta Drugs and Can Fin Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beta Drugs and Can Fin

The main advantage of trading using opposite Beta Drugs and Can Fin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Can Fin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Can Fin will offset losses from the drop in Can Fin's long position.
The idea behind Beta Drugs and Can Fin Homes pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings